Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, December 5, 2022
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
[ Mon, Dec 05th 2022
] - WOPRAI
Geoff Meacham Maintained (ABBV) at Hold with Increased Target to $162 on, Dec 5th, 2022
Geoff Meacham of B of A Securities, Maintained "AbbVie Inc." (ABBV) at Hold with Increased Target from $160 to $162 on, Dec 5th, 2022.
Geoff has made no other calls on ABBV in the last 4 months.
There are 10 other peers that have a rating on ABBV. Out of the 10 peers that are also analyzing ABBV, 4 agree with Geoff's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Justin Smith of "Societe Generale" Downgraded from Strong Buy to Hold on, Tuesday, November 8th, 2022
- Navin Jacob of "UBS" Maintained at Hold with Increased Target to $147 on, Monday, October 31st, 2022
- Steve Chesney of "Atlantic Equities" Maintained at Hold with Decreased Target to $157 on, Monday, October 31st, 2022
- Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $155 on, Monday, October 31st, 2022
These are the ratings of the 6 analyists that currently disagree with Geoff
- Trung Huynh of "Credit Suisse" Initiated at Buy and Held Target at $170 on, Friday, November 18th, 2022
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $178 on, Monday, October 31st, 2022
- Gary Nachman of "BMO Capital" Maintained at Buy with Decreased Target to $169 on, Monday, October 31st, 2022
- David Risinger of "SVB Leerink" Maintained at Sell with Decreased Target to $135 on, Friday, September 30th, 2022
- Terence Flynn of "Morgan Stanley" Reiterated at Buy and Held Target at $188 on, Wednesday, September 14th, 2022
- Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Decreased Target to $155 on, Wednesday, August 24th, 2022
